• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Quality of Life and Patient Outcomes in mCRC Treatment

Opinion
Video

Experts discuss practical strategies used by their institutions to manage treatment-related toxicities with third-line therapies for metastatic colorectal cancer (mCRC) and share their experiences on how third-line therapy options have impacted patients’ quality of life.

Video content above is prompted by the following:

  • What practical strategies does your institution use to manage treatment-related toxicities with third-line therapies for mCRC?
  • In your experience, how have the third-line therapy options impacted your patients’ quality of life?

Related Videos
1 expert is featured in this series.
3 experts are featured in this series.
2 experts in this video
1 expert is featured in this series.
© 2025 MJH Life Sciences
AJMC®
All rights reserved.